Introduction:
Calcium pyrophosphate crystal deposition disease (CPPD) is a condition and form of arthritis. It is caused by the accumulation of calcium pyrophosphate-dehydrated crystals in the bone joints, which suddenly causes severe joint pain and inflammation. This condition is also known as pseudo gout, but unlike gout, where uric acid crystals are deposited, CPPD is caused by calcium crystals.
The exact cause of CPPD is not fully known, but several factors are thought to contribute to the development of this disease. It is more common in older adults, particularly individuals over 60. Furthermore, genetic predisposition increases the risk of developing the condition.
Conditions like hyperparathyroidism, hemochromatosis, hypomagnesemia, and hypophosphatasia make people more likely to suffer from this disease. Individuals who have previously injured joints and those with osteoarthritis are more susceptible, although the exact link is unknown.
What are The Pathological Aspects of Calcium Pyrophosphate Crystal Deposition Disease?
The pathophysiology of calcium pyrophosphate crystal deposition disease includes:
1. Crystal Formation and Deposition - The primary pathological feature of CPPD is the formation and deposition of calcium pyrophosphate dihydrate (CPP) crystals inside the joints. This happens by
-
Nucleation of Crystals - The calcium pyrophosphate ions aggregate together to form the calcium pyrophosphate crystals. Factors leading to this nucleation process include increased local concentrations of calcium or pyrophosphate, changes in cartilage matrix composition, and enzymatic activity, which imbalances the pyrophosphate metabolism.
-
Growth and Clumping Of Crystals - Once the calcium pyrophosphate crystals are nucleated, they grow and clump together inside the cartilage and the synovial fluid (the joint fluid). These crystals can be seen in the fibrocartilage, periarticular tissues, synovium, fibrocartilage, and periapical tissues.
-
Release of CPP Crystals in Joint Space - Mechanical stress, such as injury or trauma to the cartilage, releases calcium pyrophosphate crystals into the joint space, which leads to the inflammatory response.
2. Inflammatory Response - The pathological effects of CPPD are significantly affected by the body's inflammatory response to the crystals deposited in the joint spaces.
The sequence of events in inflammation is as follows -
-
Crystal Phagocytosis - This happens because immune cells recognize the crystals released in the joint as foreign bodies, particularly macrophages and neutrophils. These cells attempt to ingest the crystals, which is called phagocytosis.
-
Cytokine Release - The phagocytosis of CPP crystals stimulates the action of proinflammatory cytokines such as interleukin 1, interleukin 6, and tumor necrosis factors, which magnamise the inflammatory response.
-
Damage in Tissue - The release of cytokines prominently in hyaline and other inflammatory mediators recruits additional immune cells to the joint, resulting in acute inflammation. This leads to characteristic signs of inflammation, which include redness, swelling, heat, and pain. Chronic inflammation causes synovitis (inflammation of the synovial membrane), the degradation of cartilage, and joint damage.
3. Joint Changes - With time, the CPP gradually changes the structure of the affected joints.
-
Chondrocalcinosis - This is the deposition of calcium crystals in the cartilage, more prominently in hyaline and fibrocartilage. This causes the calcification that can be seen on the radiographic image.
-
Cartilage Degeneration - Chronic inflammation and the presence of crystals can degrade the quality of the cartilage, leading to the narrowing of the joint space and changes that resemble osteoarthritis.
-
Synovial Changes - In long-standing cases of CPPD, the synovium thickens and swells. This causes joint pain and dysfunction.
-
Bone and Joint Degradation - In severe cases, inflammation and crystal deposition cause Robison of the bone and joint structures. This leads to deformities and significant functional dysfunction.
4. Biochemical Factors - There are many biological and chemical factors that influence the pathogenesis of CPPD. It includes
-
Metabolism of Pyrophosphate - Poorly regulated pyrophosphate metabolism is the significant factor in CPPD. Enzymes like tissue-nonspecific alkaline phosphatase (TNAP) and nucleotide pyrophosphatase plays a crucial role in regulating the level of pyrophosphate in cartilage.
-
Calcium Homeostasis - Imbalance in calcium homeostasis, is affected by the levels of vitamin D, parathyroid hormone, and magnesium. The imbalance in these can cause the deposition of calcium crystals.
-
Changes in Cartilage Matrix - Changes in the composition and properties of the cartilage matrix, such as altered proteoglycans and collagen, can affect normal crystal nucleation and growth and contribute to the formation of calcium crystals.
What are The Types Of Calcium Pyrophosphate Deposition Disease?
-
Acute CPP (Pseudogout) - It is a sudden-onset pain accompanied by swelling and heat in the affected joint. In some cases, it may cause fever. This condition mostly affects the wrists, shoulders, ankles, and elbows.
-
Chronic CPP Inflammatory Arthritis - The person suffering from this condition has persistent swelling and joint pain with morning stiffness in joints. This is similar to rheumatoid arthritis in clinical signs.
-
Asymptomatic CPPD - There is no noticeable symptom. The crystals are incidentally found on X-rays.
What Is the Diagnosis Of Calcium Pyrophosphate Deposition Disease?
The diagnosis is generally made on the basis of clinical examinations, imaging studies such as X-rays, and examinations of joint fluids to detect calcium crystals.
What Is the Treatment and Prognosis of CPPD?
While there is no ultimate cure for this condition, treatment aims to relieve the symptoms. Painkillers, steroid injections, and physical therapies can relieve symptoms. In a few cases, joint aspiration to remove excess fluid may be considered to relieve pressure and pain. Long-term management involves controlling inflammation and joint damage. Lifestyle changes, like maintaining a healthy weight and staying active, can help manage the symptoms.
Conclusion:
CPPD is a challenging condition that requires a comprehensive approach to diagnosis and treatment. Early diagnosis and timely treatment are essential to managing the symptoms, preventing further damage, and improving the outcomes. Understanding the pathogenesis of calcium pyrophosphate deposition disease is critical for developing targeted treatments and management strategies. Research into the molecular and cellular mechanisms of crystal formation continues to be an important area of study, focusing on improving the outcomes of individuals who suffer from this condition.
